The news: CVS filed to trademark its pharmacy, health clinics, and retail goods in the metaverse, per CNBC.
Trendspotting: There’s been a cluster of corporate metaverse filings since Facebook’s rebrand to Meta, including companies like Walmart and Nike, according to CNBC.
Still confused about what the metaverse is? Click here to read our primer.
We saw this coming: CVS’ filing aligns with our prediction that a retail player would be the first large healthcare player to dip its toes into the metaverse.
Last month, we said it would be difficult for a major health system like Kaiser Permanente to launch its own metaverse. Such an endeavor would require hospitals to overhaul their business models for reimbursement from commercial health insurers and government health plans.
At the same time, we said it was more likely for a large retail player like CVS Health (with a market cap of $140 billion) to build its own metaverse, combining services like its pharmacy and primary care services to be delivered through augmented reality or mixed reality. It appears CVS is planning to do just that.
The bigger picture: Besides reimbursement, there’s a major barrier that could slow down the launch of metaverses in any industry: connectivity.
A few weeks ago, Meta revealed that building its metaverse won’t be possible unless there are sweeping improvements to telecom networks, since glasses and VR headsets require more advanced connectivity than tech like a smartphone.
To learn more about Meta’s plan to take on the metaverse, check out our Connectivity & Tech briefing article from 2/22 here.
What’s next? Some digital health startups were already deploying augmented reality to treat chronic pain or assist with surgery before the term “metaverse” even took off. These immersive experiences are what will likely continue to define the healthcare metaverse over the next year.
For example, Osso VR uses Oculus headsets to train surgeons on certain procedures before entering the operating room, which should go a long way toward improving performance.
And last year, AppliedVR announced a one-year partnership with clinical study platform Curebase to run five clinical trials assessing the effectiveness of VR-based therapy to manage and treat chronic pain.
Still, VR headsets to treat conditions like chronic pain are relatively new in the healthcare space. Now that the metaverse is a buzzy topic in tech, we could see startups like AppliedVR get more traction from new investors over the next year to improve its platform and release more clinical research touting its effectiveness as an alternative to pain meds, for instance.
Keep reading: To learn more about how healthcare will look like in the metaverse, check out our Analyst Take: “Welcome to the metaverse: The doctor will see your avatar now.”